🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT02724371
Active, not recruiting Not applicable

A Study of the Safety and Effectiveness of the Mentor Larger Size MemoryGel Ultra High Profile Breast Implants in Subjects Who Are Undergoing Primary Breast Reconstruction or Revision Reconstruction

NCT02724371 · tracked via the Priya Life Science USA tracker
Sponsor
Mentor Worldwide, LLC
Phase
Not applicable
Started
2016-04-01
Last updated
2026-08-28

Condition(s) studied

Breast ReconstructionRevision Breast Reconstruction

Investigational drug(s) / intervention(s)

Mentor Larger Size MemoryGel Ultra High Profile Breast Implant

Mentor Larger Size MemoryGel Ultra High Profile Breast Implant: The Mentor smooth larger size MemoryGel® Ultra High Profile (UHP-L) breast implants are large round silicone gel-filled breast implants. The devices are made with cross linked layers of silicone to provide the prosthesis with elasticity and integrity.

Study summary

The study will evaluate the long-term safety and effectiveness with the Mentor MemoryGel® Larger Size Ultra High Profile (UHP-L) Breast Implants.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Subject is female and is at least 18 years old * A candidate for: * Primary breast reconstruction in women at least 18 years old with surgically absent breast tissue (two-stage reconstruction \[tissue expanders utilized with or without the use of human acellular dermal matrices (ADM), limited to AlloDerm® and FlexHD® PLIABLE, utilized in a prior surgery to expand tissue for study device placement\] to replace breast tissue post-mastectomy) * Revision surgery in women at least 18 years old with surgically absent breast tissue (previous reconstruction with silicone-filled or saline-filled implants or revision reconstruction requiring expansion surgery prior to surgery for study device implantation, with or without the use of human acellular dermal matrices (ADM), limited to AlloDerm® and FlexHD® PLIABLE, utilized in a prior surgery to expand tissue for study device placement) * Subject understands and signs the Informed Consent * Subject agrees to return device to Mentor if device is explanted * Subject agrees to comply with follow-up procedures, including returning for all follow-up visits * Physician determines implant volume appropriate for the patient taking into account the subject's BMI and chest width Exclusion Criteria: * Subject is pregnant at time of enrollment * Subject is a current smoker, or has smoked within 3 months prior to enrollment, or plans to resume smoking within 3 months post-enrollment * Currently has uncontrolled diabetes (at time of screening or enrollment) * Has nursed a child within 3 months of study enrollment * Confirmed or suspected diagnosis of the following rheumatological autoimmune diseases or immune compromised status: SLE, Sjogren's syndrome, scleroderma, polymyositis, or any connective tissue disorder, rheumatoid arthritis, crystalline arthritis, infectious arthritis, spondyloarthropathies, any other inflammatory arthritis, fibromyalgia, or chronic fatigue syndrome * Currently has a condition that could compromise or complicate wound healing. Note, obesity alone is not an exclusion. All surgical risk factors (obesity, diabetes, smoking history, and prior radiation) should be considered in totality for proper subject selection * Infection or abscess anywhere in the body * Demonstrates tissue characteristics that are clinically incompatible with successful use of a breast implant (e.g. inadequate tissue or compromised vascularity) * Possesses any condition, or is under treatment for any condition which, in the opinion of the investigator and/or consulting physicians(s), may constitute an unwarranted surgical risk * Anatomic or physiologic abnormality that could lead to significant postoperative adverse events * Demonstrates characteristics that are unrealistic/unreasonable with the risks involved with the surgical procedure * Untreated active, or inappropriately/inadequately treated breast malignancy, without surgical treatment * Anticipated need for use of ADM/mesh at the time of implant or implant exchange * Subject is HIV positive * Works for Mentor or the study doctor or is directly related to anyone who works for Mentor or the study doctor * Implanted metal or metal devices that make a MRI scan prohibitive, history of claustrophobia or other condition that would make a MRI scan prohibitive

Primary outcome measure(s)

Trial sites (30)

FacilityCityRegionStatus
Plastic Surgery Associates of Montgomery Montgomery Alabama
Mosharrafa Plastic Surgery Phoenix Arizona
Mayo Clinic Arizona - Scottsdale/Phoenix (MCSB) Phoenix Arizona
Andres Plastic Surgery Scottsdale Arizona
Adventist Health Bakersfield Bakersfield California
Susan E Downey MD, Inc Burbank California
Liu Plastic Surgery Los Gatos California
Stanford University School of Medicine Stanford California
Buckhead Plastic Surgery, P.C Atlanta Georgia
Georgia Institute of Plastic Surgery Savannah Georgia
The Centre, PC Mishawaka Indiana
University of Iowa Hospitals & Clinics Iowa City Iowa
The University of Kansas Kansas City Kansas
Abbott Northwestern Hospital Minneapolis Minnesota
Washington University School of Medicine St Louis Missouri
The Mount Sinai Medical Center New York New York
Plastic Surgery Institute of Dayton Centerville Ohio
The Plastic Surgery Group Cincinnati Ohio
The Cleveland Clinic Cleveland Ohio
The Ohio State University Plastic Surgery Columbus Ohio
Legacy Good Samaritan Medical Center Portland Oregon
Paul Glat, MD, PC Bala-Cynwyd Pennsylvania
Hospital of the University of Pennsylvania Philadelphia Pennsylvania
The Center for Dermatology and Plastic Surgery at Springbrook Alcoa Tennessee
The Plastic Surgery Group PC Chattanooga Tennessee
Vanderbilt University Medical Center Nashville Tennessee
Houston Methodist Hospital Houston Texas
The University of Texas MD Anderson Cancer Center Houston Texas
Baylor Scott & White Health Temple Texas
UVA Health System Charlottesville Virginia

More Mentor Worldwide, LLC trials in the USA

Memory Gel and Shape Combined Cohort Active, not recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT02724371 on ClinicalTrials.gov ↗ ← All trials in the USA